PAHC 240920 2.50C (PAHC240920C2500) Stock Options, News & Quotes

US OptionsDetailed Quotes

PAHC240920C2500

Watchlist

10.59
0.000.00%

15min DelayTrading Apr 4 10:48 ET

0.00High0.00Low

Intraday

5D
Daily

News

Phibro Animal Health To Go Ex-Dividend On September 4th, 2024 With 0.12 USD Dividend Per Share
Moomoo NewsSep 2 21:00 ET
Phibro Animal Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Yahoo FinanceSep 2 15:28 ET
Phibro Animal Health Is Maintained at Underperform by B of A Securities
Dow JonesAug 30 08:15 ET · Ratings
Phibro Animal Health Analyst Ratings
BenzingaAug 30 08:04 ET · Ratings
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $15
Moomoo NewsAug 30 05:32 ET · Ratings
Barclays Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Maintains Target Price $13
Moomoo NewsAug 30 04:32 ET · Ratings

Comments

Moomoo AI

Dec 6, 2023 04:43

Phibro Animal Health's unsatisfactory ROE indicates potential risk due to high leverage. Investors should consider the risks of high debt levels and low ROE.

Is Phibro Animal Health Corporation's (NASDAQ:PAHC) 7.6% ROE Worse Than Average?

Mcsnacks H Tupack

Sep 2, 2021 02:00

Insider selling:
$VIZIO (VZIO.US)$
$Fulgent Genetics (FLGT.US)$
$Cara Therapeutics (CARA.US)$
$KnowBe4 (KNBE.US)$
$Coursera (COUR.US)$
$Intellia Therapeutics (NTLA.US)$
$Natera (NTRA.US)$
$DraftKings (DKNG.US)$
$Natural Alternatives International (NAII.US)$
$Revolve Group (RVLV.US)$
$A10 Networks (ATEN.US)$
$Zuora (ZUO.US)$
Insider Buying
$Spero Therapeutics (SPRO.US)$
$Lumos Pharma (LUMO.US)$
$Oscar Health (OSCR.US)$
$Phibro Animal Health (PAHC.US)$